Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss
A Randomized, Double-Blind, Controlled Study to Assess the Efficacy of a Tea Catechin Sports Drink for Enhancing Exercise-Induced Fat Loss
1 other identifier
observational
132
1 country
2
Brief Summary
The primary objective of this trial is to evaluate the influence of consuming a tea catechin containing sports beverage on body fat mass during exercise-induced weight loss among overweight and obese men and women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2006
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 4, 2008
CompletedFirst Posted
Study publicly available on registry
June 6, 2008
CompletedJune 6, 2008
June 1, 2008
1.1 years
June 4, 2008
June 4, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in body fat mass.
Baseline to end-of-treatment
Secondary Outcomes (1)
Changes in body weight
Baseline to end-of-treatment
Study Arms (2)
Active
Tea catechin sport beverage
Control
Control beverage
Interventions
Subjects were asked to consume 500 mL/day of a beverage providing approximately 625 mg catechins
500 mL/day of a control beverage
Eligibility Criteria
Subjects included generally healthy, normally sedentary men and women. Eligible participants were required to be 21 to 65 years of age, have a waist circumference ≥ 87 cm (women) or ≥ 90 cm (men), and total cholesterol ≥ 200 mg/dL at screening.
You may qualify if:
- Men and women 21 to 65 years of age, inclusive
- Waist circumference ≥ 87 cm for women and ≥ 90 cm for men at screening
- Total cholesterol ≥ 200 mg/dL
- Provide written informed consent and authorization for protected health information
You may not qualify if:
- Volunteers with Body mass index ≥ 40.0 kg/m2 or \< 25.0 kg/m2;
- Recent weight loss of more than 4.5 kg;
- Recent use of any weight loss medications, supplements, or programs;
- History of weight-reducing surgery or an eating disorder
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Provident Clinical Researchlead
- Kao (Taiwan) Corporationcollaborator
Study Sites (2)
Meridien Research
St. Petersburg, Florida, 33709, United States
Provident Clinical Research
Bloomington, Indiana, 47403, United States
Related Publications (4)
Murase T, Nagasawa A, Suzuki J, Hase T, Tokimitsu I. Beneficial effects of tea catechins on diet-induced obesity: stimulation of lipid catabolism in the liver. Int J Obes Relat Metab Disord. 2002 Nov;26(11):1459-64. doi: 10.1038/sj.ijo.0802141.
PMID: 12439647BACKGROUNDDulloo AG, Duret C, Rohrer D, Girardier L, Mensi N, Fathi M, Chantre P, Vandermander J. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999 Dec;70(6):1040-5. doi: 10.1093/ajcn/70.6.1040.
PMID: 10584049BACKGROUNDNagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr. 2005 Jan;81(1):122-9. doi: 10.1093/ajcn/81.1.122.
PMID: 15640470BACKGROUNDNagao T, Hase T, Tokimitsu I. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 2007 Jun;15(6):1473-83. doi: 10.1038/oby.2007.176.
PMID: 17557985BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kevin C Maki, PhD
Provident Clinical Research
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 4, 2008
First Posted
June 6, 2008
Study Start
June 1, 2006
Primary Completion
July 1, 2007
Study Completion
August 1, 2007
Last Updated
June 6, 2008
Record last verified: 2008-06